GO:0070034 telomerase RNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070034 (telomerase RNA binding) is a molecular function describing the binding of a protein to the telomerase RNA template, also known as TERC binding.
• The telomerase reverse transcriptase (TERT) contains a dedicated RNA binding domain that directly interacts with the telomerase RNA template.
• Telomerase RNA is more than a simple template; it provides structural and regulatory functions essential for telomerase assembly and activity.
• Biogenesis of telomerase RNA involves sequential binding by Sm and Lsm protein complexes, which are critical for its processing and stability.
• CIRP/hnRNP A18 regulates telomerase activity in a temperature-dependent manner by binding to telomerase RNA.
• TERC stimulates fatty acid metabolism to promote bladder cancer progression, linking telomerase RNA binding to metabolic reprogramming in cancer.
Description
Telomerase RNA binding (GO:0070034) is a molecular function that defines the interaction between a protein and the RNA component of telomerase, known as TERC (telomerase RNA component). This binding event is fundamental to the assembly and activity of the telomerase ribonucleoprotein complex, which maintains telomere length and chromosomal stability. The telomerase reverse transcriptase (TERT) is the primary protein that binds telomerase RNA, and this interaction is essential for the enzyme's catalytic function. Beyond TERT, other proteins such as Sm and Lsm complexes sequentially bind telomerase RNA during its biogenesis, ensuring proper processing and maturation. The importance of telomerase RNA binding extends to human health, as dysregulation of telomerase activity is implicated in cancer, aging, and other diseases. Understanding the molecular details of this binding event is crucial for researchers studying telomere maintenance, RNA-protein interactions, and potential therapeutic interventions.
telomerase RNA binding At A Glance
| GO ID | GO:0070034 |
|---|---|
| GO term | telomerase RNA binding |
| Ontology | molecular_function |
| Synonym | TERC binding |
| Major function | Binding to the telomerase RNA template, facilitating telomerase complex assembly and activity. |
| Related genes | TERT, TERC, CIRP/hnRNP A18, Sm and Lsm complexes |
| Associated diseases | Cancer, aging-related disorders, and potentially other telomere-related pathologies |
| Research methods | RNA immunoprecipitation, electrophoretic mobility shift assays, CRISPR knockout, and overexpression models |
What Is GO:0070034?
According to the Gene Ontology, GO:0070034 (telomerase RNA binding) is defined as the binding to the telomerase RNA template. This molecular function encompasses the selective and non-covalent interaction between a protein and the RNA component of telomerase, which serves as the template for telomere repeat synthesis. The synonym TERC binding is often used interchangeably. This function is distinct from other RNA-binding activities because it specifically targets the telomerase RNA template, a long non-coding RNA that is essential for telomerase function.
Why Is telomerase RNA binding Important in Cell Biology?
Telomerase RNA binding is a critical molecular function because it underpins the assembly and activity of telomerase, the enzyme responsible for maintaining telomere length and chromosomal integrity. Without proper binding of TERT to TERC, telomerase cannot elongate telomeres, leading to progressive telomere shortening, cellular senescence, and aging. In cancer, telomerase is often reactivated to support unlimited proliferation, and disruptions in telomerase RNA binding can affect tumor growth and progression. Moreover, telomerase RNA binding is involved in the biogenesis and regulation of TERC, with proteins such as CIRP modulating telomerase activity in response to temperature stress. Therefore, studying this function provides insights into fundamental cellular processes and offers potential targets for therapeutic intervention in cancer and age-related diseases.
• Essential for telomerase enzyme assembly and telomere maintenance.
• Dysregulation leads to telomere shortening and cellular aging.
• Telomerase reactivation is a hallmark of many cancers, making this function a therapeutic target.
• TERC binding proteins like CIRP regulate telomerase activity under stress conditions.
• Sm and Lsm complexes sequentially bind TERC during biogenesis, affecting RNA stability.
• Telomerase RNA binding is implicated in metabolic reprogramming in bladder cancer.
• Understanding this function aids in designing inhibitors or activators of telomerase.
• It serves as a model for studying long non-coding RNA-protein interactions.
• Mutations in TERT or TERC can affect binding and are linked to disease.
• Research on this function can inform regenerative medicine and anti-aging strategies.
Molecular Mechanism of telomerase RNA binding
TERT RNA Binding Domain
In simple terms: The TERT protein has a special region that grabs onto the telomerase RNA.
The telomerase reverse transcriptase (TERT) contains a dedicated RNA binding domain that directly interacts with the telomerase RNA template. This domain is essential for the catalytic activity of telomerase, as it positions the RNA template for reverse transcription of telomeric DNA repeats. The binding is highly specific, ensuring that TERT recognizes TERC among other cellular RNAs. Structural studies have revealed that the RNA binding domain undergoes conformational changes upon binding, which may regulate enzyme activity.
Sequential Binding by Sm and Lsm Complexes
In simple terms: Other proteins bind to the telomerase RNA in a step-by-step manner to help it mature.
During the biogenesis of telomerase RNA, the Sm and Lsm protein complexes bind sequentially to TERC. This sequential binding is crucial for the processing, stability, and nuclear export of the RNA. The Sm complex binds first, followed by the Lsm complex, which together ensure proper 3' end processing and assembly of the telomerase holoenzyme. Disruption of this sequential binding impairs telomerase function and leads to telomere shortening.
Regulation by CIRP/hnRNP A18
In simple terms: A protein called CIRP can attach to telomerase RNA and control its activity depending on temperature.
CIRP (cold-inducible RNA-binding protein), also known as hnRNP A18, regulates telomerase activity in a temperature-dependent manner by binding to telomerase RNA. Under cold stress, CIRP binds to TERC and enhances telomerase activity, while at normal temperatures, this interaction is reduced. This regulation links telomerase function to cellular stress responses and highlights the dynamic nature of telomerase RNA binding.
TERC as a Scaffold for Protein Interactions
In simple terms: The telomerase RNA acts as a platform where many proteins can dock.
Telomerase RNA (TERC) is more than a DNA template; it serves as a scaffold for the assembly of the telomerase complex. It contains structural domains that recruit TERT and other accessory proteins, facilitating their binding and coordinating their activities. This scaffolding function is essential for the proper folding and function of the telomerase holoenzyme, and it allows for regulation by various cellular factors.
Role in Telomere Elongation
In simple terms: Once the RNA is bound, the enzyme can add DNA repeats to the ends of chromosomes.
The binding of TERT to telomerase RNA is a prerequisite for telomere elongation. After binding, the RNA template is positioned within the active site of TERT, allowing the reverse transcriptase to synthesize telomeric DNA repeats. This process is critical for maintaining telomere length and preventing chromosomal instability. Defects in this binding step result in telomerase deficiency and progressive telomere shortening.
Key Genes Involved in GO:0070034 telomerase RNA binding
The following genes and proteins are key players in telomerase RNA binding and its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TERT | Catalytic subunit of telomerase; binds telomerase RNA template | Central to telomerase activity; mutations affect binding and are linked to cancer and aging |
| TERC | Telomerase RNA component; provides template and scaffold | Essential for telomerase function; mutations cause dyskeratosis congenita and other diseases |
| CIRP (hnRNP A18) | RNA-binding protein that regulates telomerase activity in a temperature-dependent manner | Modulates telomerase under stress; potential target for cancer therapy |
| Sm complex proteins | Bind TERC during biogenesis; involved in RNA processing | Required for telomerase RNA maturation; defects affect telomerase assembly |
| Lsm complex proteins | Sequentially bind TERC after Sm complex; involved in RNA stability | Critical for telomerase RNA biogenesis; mutations may lead to disease |
| DKC1 | Dyskerin; associated with telomerase RNA stability and modification | Mutations cause dyskeratosis congenita; affects telomerase RNA binding indirectly |
| NOP10 | Part of H/ACA ribonucleoprotein complex; stabilizes TERC | Mutations linked to dyskeratosis congenita; affects telomerase RNA accumulation |
| NHP2 | H/ACA ribonucleoprotein component; binds TERC | Essential for telomerase RNA stability; disease-associated mutations |
| GAR1 | H/ACA ribonucleoprotein component; binds TERC | Required for telomerase RNA processing; implicated in dyskeratosis congenita |
| TCAB1 | Telomerase Cajal body protein 1; facilitates TERC localization | Mutations cause dyskeratosis congenita; affects telomerase trafficking |
| PARN | Poly(A)-specific ribonuclease; regulates TERC 3' end processing | Mutations linked to dyskeratosis congenita; affects TERC maturation |
| hnRNP A1 | RNA-binding protein; may compete with TERT for TERC binding | Potential regulator of telomerase assembly; under investigation |
| La protein | Binds telomerase RNA; involved in RNA stabilization | Affects telomerase RNA half-life; potential therapeutic target |
| LARP7 | La-related protein 7; binds telomerase RNA | Regulates telomerase RNA stability; mutations may affect telomerase |
| SMN complex | Survival motor neuron complex; involved in Sm core assembly | Mutations cause spinal muscular atrophy; may affect telomerase RNA biogenesis |
| TDP-43 | RNA-binding protein; may interact with telomerase RNA | Linked to neurodegeneration; potential role in telomerase regulation |
| FUS | RNA-binding protein; may bind telomerase RNA | Implicated in ALS; potential impact on telomerase function |
| TERRA | Telomeric repeat-containing RNA; may compete with TERC for binding | Regulates telomerase activity; potential biomarker |
How Is telomerase RNA binding Regulated?
Telomerase RNA binding is regulated at multiple levels. The expression of TERT and TERC is tightly controlled, and post-translational modifications of TERT can affect its RNA binding affinity. Additionally, proteins such as CIRP modulate telomerase activity in response to temperature stress, demonstrating environmental regulation. The sequential binding of Sm and Lsm complexes during TERC biogenesis provides a quality control mechanism for telomerase assembly. Furthermore, the availability of accessory proteins and the cellular localization of TERC within Cajal bodies influence the efficiency of telomerase RNA binding.
telomerase RNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TERT | Cancer, dyskeratosis congenita, aging | CRISPR knockout in cancer cell lines; point mutations to disrupt RNA binding |
| TERC | Dyskeratosis congenita, cancer | Knockout in HEK293T; overexpression of mutant TERC |
| CIRP | Cancer, stress response | Conditional knockout in mouse models; temperature-shift experiments |
| DKC1 | Dyskeratosis congenita | Patient-derived iPSCs; CRISPR correction of mutations |
| TCAB1 | Dyskeratosis congenita | Knockout in HeLa cells; localization studies |
Cancer
Telomerase is reactivated in approximately 90% of human cancers, and telomerase RNA binding is essential for its activity. Disruptions in the binding of TERT to TERC can impair telomere maintenance and inhibit tumor growth. Recent studies have shown that TERC stimulates fatty acid metabolism to promote bladder cancer progression, linking telomerase RNA binding to metabolic reprogramming. Targeting the interaction between TERT and TERC is a promising therapeutic strategy for cancer.
Dyskeratosis Congenita and Telomere Biology Disorders
Mutations in genes involved in telomerase RNA binding, such as TERT, TERC, DKC1, and TCAB1, cause dyskeratosis congenita, a rare inherited bone marrow failure syndrome characterized by short telomeres. These mutations often impair the binding of TERT to TERC or affect the stability of the telomerase complex, leading to telomere shortening and disease.
Aging and Age-Related Diseases
Progressive telomere shortening is a hallmark of aging, and telomerase RNA binding is critical for telomere maintenance. Introduction of telomerase into normal human cells extends their lifespan, highlighting the importance of telomerase RNA binding in cellular aging. Dysregulation of this function may contribute to age-related pathologies, including cardiovascular disease and neurodegeneration.
From telomerase RNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TERT bind TERC directly? | In vitro RNA pull-down with recombinant TERT; electrophoretic mobility shift assay |
| What is the role of CIRP in telomerase regulation? | CIRP knockout cells; temperature-dependent telomerase activity assays |
| How do Sm/Lsm complexes affect TERC biogenesis? | siRNA knockdown of Sm/Lsm components; RNA immunoprecipitation |
| Can mutations in TERT RNA binding domain cause disease? | CRISPR point mutation knock-in in cell lines; telomere length measurement |
| Does TERC overexpression promote cancer? | Xenograft models with TERC-overexpressing cancer cells |
| What is the effect of telomerase reactivation on aging? | TERT overexpression in normal human fibroblasts; lifespan analysis |
How to Study the telomerase RNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA immunoprecipitation (RIP) | Binding of proteins to telomerase RNA in vivo | Assessing TERT-TERC interaction under different conditions |
| Electrophoretic mobility shift assay (EMSA) | Direct binding affinity and specificity | Testing mutant TERT RNA binding domains |
| CRISPR-Cas9 knockout | Loss-of-function effects on telomerase RNA binding | Creating TERT or TERC knockout cell lines |
| CRISPR point mutation | Effect of specific amino acid changes on RNA binding | Modeling disease-associated mutations in TERT |
| RNA-seq | Global gene expression changes | Identifying pathways affected by telomerase RNA binding |
| Telomere length assay (TRF) | Telomere length maintenance | Evaluating functional consequences of binding defects |
| Immunofluorescence | Subcellular localization of telomerase components | Studying TERC trafficking to Cajal bodies |
| Proteomics | Identification of telomerase-associated proteins | Discovering novel TERC-binding proteins |
RNA Immunoprecipitation (RIP)
RIP is used to detect the binding of proteins to telomerase RNA in vivo. By immunoprecipitating TERT or other RNA-binding proteins and quantifying associated TERC via RT-qPCR, researchers can assess the interaction under different conditions. This method is valuable for studying dynamic changes in telomerase RNA binding in response to cellular signals.
Electrophoretic Mobility Shift Assay (EMSA)
EMSA is an in vitro technique to measure direct binding of purified proteins to radiolabeled or fluorescently labeled telomerase RNA. It allows determination of binding affinity and specificity, and can be used to test the effects of mutations in the RNA binding domain of TERT.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is employed to create knockout or point-mutation cell models to study the functional consequences of disrupting telomerase RNA binding. For example, knocking out TERT or introducing mutations in its RNA binding domain can reveal effects on telomere length and cell proliferation.
RNA Sequencing (RNA-seq)
RNA-seq can be used to analyze global changes in gene expression upon modulation of telomerase RNA binding, such as after TERC overexpression or knockout. This approach can identify downstream pathways affected by telomerase activity, including metabolic reprogramming in cancer.
How CRISPR Can Be Used to Study GO:0070034 telomerase RNA binding
Knockout
CRISPR knockout of TERT or TERC abolishes telomerase RNA binding and telomerase activity, leading to progressive telomere shortening. These models are used to study the consequences of telomerase deficiency in cancer and aging.
Point Mutation
Point mutations in the RNA binding domain of TERT can be introduced using CRISPR to dissect the specific residues required for TERC binding. Such models help understand how disease-associated mutations affect telomerase function.
Knock-in
Knock-in of tagged TERT or TERC allows for affinity purification and imaging of the telomerase complex. This approach facilitates the study of telomerase RNA binding dynamics and interactome.
Overexpression
Overexpression of TERT or TERC using CRISPR activation or lentiviral vectors can enhance telomerase activity and telomere elongation. This is useful for studying the effects of increased telomerase RNA binding in cancer and regenerative medicine.
How EDITGENE Supports telomerase RNA binding Research
Researchers studying telomerase RNA binding-related genes often need to determine whether a candidate gene is causally involved in telomerase function, telomere maintenance, or disease progression. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for telomerase RNA binding research.
Frequently Asked Questions About telomerase RNA binding
What is GO:0070034?
GO:0070034 is the Gene Ontology term for telomerase RNA binding, a molecular function defined as binding to the telomerase RNA template.
What genes are involved in telomerase RNA binding?
Key genes include TERT, TERC, CIRP, and components of the Sm and Lsm complexes.
How does telomerase RNA binding affect telomere length?
Binding of TERT to TERC is required for telomerase activity, which elongates telomeres and maintains chromosomal stability.
What diseases are associated with defects in telomerase RNA binding?
Defects can cause dyskeratosis congenita, cancer, and age-related disorders.
What methods are used to study telomerase RNA binding?
Common methods include RNA immunoprecipitation, EMSA, CRISPR knockout, and RNA-seq.
Can CRISPR be used to study telomerase RNA binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect this function.
What is the role of CIRP in telomerase RNA binding?
CIRP regulates telomerase activity in a temperature-dependent manner by binding to telomerase RNA.
How does TERC stimulate cancer progression?
TERC can promote fatty acid metabolism to support cancer cell growth, as shown in bladder cancer.
What is the difference between TERC and TERT?
TERC is the RNA component that provides the template, while TERT is the protein that binds TERC and catalyzes telomere extension.
Why is telomerase RNA binding important for aging?
Proper binding maintains telomere length, and its decline contributes to cellular aging; telomerase introduction extends lifespan in normal cells.
Conclusion
Telomerase RNA binding (GO:0070034) is a fundamental molecular function that governs telomerase assembly and activity, with critical implications for cancer, aging, and telomere biology disorders. Understanding the precise mechanisms of TERT-TERC interaction and its regulation by proteins such as CIRP and Sm/Lsm complexes provides insights into disease pathogenesis and potential therapeutic targets. Continued research using advanced CRISPR models and biochemical assays will further elucidate this essential function.
References
- 1. Lai CK et al.. 2001. RNA binding domain of telomerase reverse transcriptase.. Mol Cell Biol 21(4):990-1000 PMID: 11158287
- 2. Webb CJ et al.. 2016. Telomerase RNA is more than a DNA template.. RNA Biol 13(8):683-9 PMID: 27245259
- 4. Zhang Y et al.. 2016. Cold-inducible RNA-binding protein CIRP/hnRNP A18 regulates telomerase activity in a temperature-dependent manner.. Nucleic Acids Res 44(2):761-75 PMID: 26673712
- 5. Siddiqa A et al.. 2006. Targeting telomerase.. Rejuvenation Res 9(3):378-90 PMID: 16859479
- 6. Chen C et al.. 2025. TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression.. Cancer Res 85(19):3689-3705 PMID: 40759031
- 7. Bodnar AG et al.. 1998. Extension of life-span by introduction of telomerase into normal human cells.. Science 279(5349):349-52 PMID: 9454332
- 8. Tang W et al.. 2012. Telomerase RNA biogenesis involves sequential binding by Sm and Lsm complexes.. Nature 484(7393):260-4 PMID: 22446625
